The efficient delivery of drugs to tumors is an important tool for the treatment of a variety of cancers. Electric pulses have been shown to facilitate the uptake of molecules through the cell membrane. This procedure has been successful in increasing the effectiveness of antitumor agents (electrochemotherapy; ECT). Response rates of >80% have been obtained in both animal and human trials for several types of skin malignancies. The study reported here examined the effect of ECT on normal tissue. The hind limbs of Sprague Dawley rats were treated with 1-3 electroporation sequences in the presence or absence of the drug (bleomycin) which was administered at 4, 8 or 16 units/ml. The treated sites were examined histologically 3, 14 and 56 days later. Limb function was not affected by the treatment and skin and muscle necrosis was only seen at the higher doses.
Introduction
Electroporation, also known as electropemeabilization, is accomplished using pulsed electric fields. Electroporation facilitates the delivery of molecules into cells by increasing the permability of cell membranes. In vivo electroporation, when used in combination with chemotherapeutic agents has been shown to be a potent antitumor treatment. This combined treatment is called electrochemotherapy (ECT). It has been used in animal models for melanomas, lung carcinomas, mammary tumors, fibrosarcomas, sarcomas, Ehrlich-Lettre Ascites carcinomas, hepatocellular carcinomas, and gliomas (1-12). The chemotherapeutic agent bleomycin has been employed for ECT animal studies almost exclusively. These studies clearly demonstrated ECT is a highly effective antitumor treatment. Findings from the animal model work were translated into clinical trials for melanoma, basal cell carcinoma, and head and neck squamous cell carcinoma (13) (14) (15) (16) (17) (18) (19) . These studies have also been highly effective. Objective response rates range from 70 to 99 percent and complete response rates range from 50 to 95 percent depending on the tumor type.
An advantage of ECT is that the potent antitumor effect can be accomplished using very low doses of a chemotherapeutic agent. In addition, the treatment yields minimal scarring and can be performed in an outpatient setting. These attributes, together with the high response rates that have been achieved, suggest that this therapy has the potential to be a powerful treatment for solid tumors. These attributes also suggest that ECT may be useful as a tissue/limb sparring procedure for soft tissues tumors of the extremities such as sarcomas.
The major concern in the treatment of extremity soft tissue sarcomas is local control and preservation of a functional limb. Presently, limb-sparing procedures involving wide local excision in combination with pre-, postor intra-operative radiation therapy are the mainstream treatment for extremity sarcoma. This multi-modality approach focuses on the eradication of the tumor while maintaining a viable limb and acceptable local recurrence rate. This minimizes the extent of surgery necessary for local control of this disease. The rate of amputation has dramatically decreased using the multi-modality approach (28-31).
Although local management of soft tissue sarcoma has improved dramatically with preoperative radiation therapy and regional chemotherapy, these are extensive and in some cases expensive procedures. In addition, wound healing is impaired with preoperative radiation and leads to an increased rate of wound infection. High dose radiation can also lead to fibrosis that leads to contracture across a joint leading to decreased mobility (31-33). One approach to decreasing the impact of preoperative treatment is to use a protocol that directly impacts the amount of necessary surgery by shrinking the tumor. Previous studies in an athymic rat sarcoma model have shown that ECT can yield high response rates (12). The study reported here examined if ECT would have an adverse effect on normal tissue as well as to determine if ECT can be administered without decreasing or impairing limb function.
Materials and Methods

Treatment
Male Spraque Dawley rats (Harlan Sprague Dawley, Inc., Indianapolis, IN, USA, 250-275 grams) were randomized into 16 groups and contained 6 rats. For treatment, rats were anesthetized in an induction chamber charged with 5% isoflurane in O 2 , then fitted with a standard rodent mask and kept under anesthesia with 3% isoflurane. For groups designated to receive drug (D+), bleomycin was injected directly into the tissue at a concentration of 4, 8 or 16 units/ml in a volume of 250 µl ten minutes prior to receiving electric pulses. The injection procedure and timing (between injection and administration of pulses) were performed to mimic how the therapy is applied to tumors (12). The area treated included both the femoral artery and nerve and the treatment was administered to include the biceps femoris muscle. The injection was performed to obtain perfusion of the entire treatment area. Two hind limbs were used in each rat, but the D + and Dtreatments were performed in separate rats. The pulsed (E+) groups received a nominal field strength of 1300 V/cm delivered via a Medpulser generator (Genetronics, Inc., San Diego, CA). Six rectangular direct current pulses were delivered to each treatment site. The duration of each pulse was 100 µs, and the duty cycle was 1 second. Pulses were delivered to each site using an applicator that consisted of six needles that were equispaced around a 1 cm diameter circle (Genetronics, Inc.). Of the three D + E + groups receiving the same bleomycin dose, one received a single treatment sequence, one received two treatment sequences and the other received three treatment sequences on day 0. All procedures performed on animals were approved by the University of South Florida Institutional Animal Care and Use Committee.
Animal Observation
The animals were observed immediately after dosing, 1 hour, and 4 hours after dosing, and once daily thereafter. The effect of treatment on limb function was evaluated by observing temporary paralysis, regaining of function, and determining tactile response of the limb (sensitivity to touch).
Tissue Evaluation
Rats were humanely euthanized 3, 14, or 56 days after treatment and tissue samples (skin down through muscle) taken from the treated area of four limbs from each group (2 rats) for examination. Samples were examined histologically for tissue integrity, cellular necrosis, inflammation and fibrosis as described below. The tissue specimens were also evaluated for their overall health and to determine if the treatment had any adverse effect on normal tissue including blood vessels and nerves.
Histological Analysis
Each specimen was fixed in 10% formalin and submitted entirely for histologic examination. Radial and sagittal sections (4 µm) were stained with Hematoxylin and Eosin (H&E) after fixation using standard histological techniques. Percent cellular necrosis was quantified as: 1A (0-5%), 1B (6-25%), 2 (26-50%), 3 (51-75%), 4 (76-100%). The multiplier factor is the midpoint of the percent necrosis range, and the artificial score is the product of the multiplier factor and the sum of the number of affected limbs. For example, if for a group of 4 limbs the necrosis was scored as follows: 2 limbs 1B and 2 limbs 2 then the artificial score would be 107 (2 × 15.5 (1B) plus 2 × 38 (2)). The amount of inflammation was quantified as: Mild Focal (1), Mild Diffuse (2), Moderate Focal (3), Moderate Diffuse (4), Severe Focal (5), Severe Diffuse (6), number in parentheses represents multiplier factor. The artificial score is the product of the multiplier factor and the sum of the number of affected limbs. To assess the structure of vessels, nerves, smooth and skeletal muscles, special stains were performed. The structure of blood vessels were evaluated by the use of elastic van Gieson and Gomori trichrome stains. Immunoperoxidase stain for smooth muscle actin was used to evaluate the vascular smooth muscle. Hematoxylin and eosin stain and toluidine blue stain was employed to evaluate the peripheral nerve compartments. Finally, the status of the skeletal muscle was examined with standard ATPase stain, highlighting type 1 and type 2 fibers. Muscle degeneration if present, can be unmasked by trichrome, oil red-O and NADH-TR stain. Enzymatic alteration was evaluated by the use of NADH-TR, acid phosphatase and esterase stains.
Statistical Evaluation
The significance of differences between the experimental and control groups were determined first by performing a student's t-test.
Results
Overview
This study was designed to determine if electrochemotherapy (ECT) had any significant adverse effects on normal tissue. To examine this, 96 male Sprague Dawley rats were divided into 16 groups as depicted in Figures 1 and 2. To fully explore the possible toxic effects of this therapy, the hind limbs of Sprague Dawley rats were treated with 3 doses of bleomycin (4, 8 and 16 units/ml) in combination with 0, 1, 2 or 3 electric pulse sequences. Each electric pulse sequence included 6 pulses at field strength of 1300 V/cm and 100 µs pulse width. On days 3, 14 and 56, two rats from each group were humanely euthanized and biopsies were performed on the four treated limbs. The evaluation was based on several criteria, which examined skin, muscle, nerves and blood vessels. Histological analysis was used to examine necrosis, inflammation and fibrosis of the tissue. The results were interpreted by assigning arbitrary scores based on the percent of necrosis or the type of inflammation (see methods). Impact of the treatment on nerves and blood vessels was also determined histologically and tactile response was used to determine functionality of the limb.
Effect of ECT on Skin
The amount of skin necrosis observed was most severe at three days after treatment. It was also noted that as the intensity (number of repeat administrations and bleomycin dose) of the treatment increased so did the amount of necrosis. The amount of necrosis was evaluated based on the severity as well as the number of affected limbs in each group. The amount and severity of the necrosis diminished over time after treatment indicating that this is a reversible event ( Figure 1A) .
Inflammation of the skin followed a similar pattern and also declined with time ( Figure 1B) . It is interesting to note that a higher amount of inflammation was seen in the groups that received electroporation alone, but the effect was present longer in the groups receiving bleomycin or bleomycin with electroporation.
The skin within the treated area was also examined histologically for evidence of fibrosis. While there was evidence of fibrosis in most of the groups, it was generally focused in a small isolated area (Focal Fibrosis, Figure 1C ). There were only two limbs (2 of 64) that exhibited diffuse fibrosis ( Figure 1D ). Both were at three days post treatment and had received 4 units of bleomycin with one receiving 1 round of electroporation and the other 2 rounds of electroporation. The amount of fibrosis also gradually decreased over time. The overall effect on the skin is summarized in Table I .
Effect of ECT on Muscle
The effect of treatment on muscle was more pronounced than that observed with skin. Muscle necrosis (Figure 2A ) was more pronounced than that found in the skin. The severity did increase in those groups that received full treatment, but there was no correlation between the intensity of the ECT protocol and the severity of the necrosis. As with the skin, the amount (number of limbs affected) and severity of necrosis also decreased over time.
With respect to inflammation, there was no correlation between the type or aggressiveness of treatment and the amount of inflammation ( Figure 2B ). Inflammation was seen in partially treated as well as ECT treated animals. Inflammation was the highest at the early time point (3 days) and for most treatment protocols the amount of inflammation decreased over time. While there was residual inflammation in most groups at 56 days, the amount was greatly reduced.
Muscle fibrosis was found in most samples, but like the skin, was mainly seen as focal fibrosis ( Figure 2C ). However, for the muscle, there were 9 limbs (9 of 64) that had diffuse fibrosis (DF, Figure 2D ). Most of the limbs showing DF were seen at the three-day time point (6 of 9) and the other three were found at 56 days. Five of the six DF at Day 3 and two of the three at Day 56 were from groups receiving 3 rounds of electroporation. Interestingly, there was no correlation of the DF with the dose of bleomycin. So, it would appear that for the muscle the intensity of the fibrosis is related to the amount of electroporation independent of the drug. The fibrosis, both in terms of affected limbs and severity, declined gradually, if at all, with time after treatment. There was little improve- ment in groups receiving drug and electric pulses between 3, 14 and 56 days. The overall effect on the muscle is summarized in Table II .
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Effect of ECT on Nerves, Blood Vessels and Function
Histological analysis was also used to determine if there was an affect on nerves and blood vessels. Very little necrosis and/or inflammation was seen for either site (Table III) . For the most part, necrosis declined with time and inflammation was minimal throughout the experimental time frame.
Tactile response was used to test limb function. No prolonged impairment was seen. The longest time to recovery was seen with the more intense electroporation protocols and appeared to be independent of the presence or dose of bleomycin. However, all limbs returned to normal function within 6 minutes of the animal's recovery from anesthesia (Figure 3) . Therefore, even though the results showed some histological damage, there was no apparent sustained functional impairment.
Discussion
Electrochemotherapy has been successful as a means to enhance the effectiveness of chemotherapeutic agents. Since electroporation is a physical phenomenon, the effect on cellular permeability can be applied to most cell types. Bleomycin appears to be the most effective drug when combined with electric pulses (19, (31) (32) (33) the antitumor effects of cisplatin has been shown to be enhanced, both in animal and clinical studies, when combined with electroporation in certain tumor types (6, (36) (37) .
Previous studies have shown that ECT is effective in treating human rhabdomyosarcoma tumors in the hind limb of athymic rats (12). ECT can be used to effectively reduce or eliminate tumors and can therefore, be an integral part of limb sparing procedures for extremity soft tissue sarcoma. This approach could greatly augment the contribution of chemotherapy in the treatment of this disease. A key consideration in using this approach is the ability to maintain function of the limb. The treatment was well tolerated by the animals. No functional impairment was observed in the limbs of animals that were treated with ECT or in those that responded completely to the treatment.
An important consideration is the effect of ECT on normal tissue. Other investigations have examined the effect of ECT on normal liver and the effect of electric fields on normal muscle (38) (39) . The results of the liver study were similar to those reported here. Necrosis of the tissue was higher when exposed to both drug and electroporation and typically resolved over time (38) . The muscle work examined thresholds where damage may begin to occur from irreversible electroporation. This also occurred at field strengths higher than those typically used to deliver molecules with electroporation (39). The present study was performed to examine the effect of ECT on skin, muscle, nerves and blood vessels in the absence of tumor. To ascertain the effect on extremities, the procedures were performed on the hind limb of rats in the absence of tumor. To fully examine the effect of ECT on tissue, dosages were used that range from the typical ECT bleomycin dose to concentrations that were up to four times as high. In addition, the electroporation protocol was administered not only as a single application but also from 1-3 times. So, evaluation was not solely based on standard ECT conditions, but also examining more extreme exposure to the treatment parameters.
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Results reported here showed that the necrosis of the skin was only seen at the highest doses of bleomycin when combined with multiple applications of electroporation. In addition, the effect was mainly observed for a short time following treatment and was resolved by Day 56. Muscle necrosis was more pronounced but also healed by Day 56 post treatment. Inflammation of both the skin and muscle showed a similar pattern. Inflammation is most apparent within 3 days after treatment but resolved over time. The results also showed that the application of electrochemotherapy did not impair function of the limb (hind limb of rat). Full function was returned within 6 minutes after treatment.
Overall, the data supports the hypothesis that ECT, even after three applications or with 4 times the typical drug dose, did not result in severe toxicity to normal tissue nor did it impair function. In addition, when toxicity was observed it was short-lived and limbs improved over time. Histology of the 56-day samples showed fewer effects than the 14-day samples, which showed fewer effects than the three-day samples.
In addition, areas of necrosis were focused and coincided with the areas directly around the electrodes. When the results of this study are combined with previous studies demonstrated the anti-tumor effectiveness of ECT, it builds a strong case for the use of this therapeutic approach to reduce or eliminate soft tissue sarcomas as part of a limb sparing procedure. 
